Side Effects and Tolerability at Higher Doses Gastrointestinal side effects including nausea, vomiting, constipation, and diarrhea occur more frequently at higher semaglutide doses, particularly during the first two weeks after each dose increase
The research also revealed that there is "a drive to prescribe, rather than making sure the patient is going to be safe in taking these medications and that the medication is going to be appropriate for them," Ramachandran said.
Wegovy, however, is among GLP-1s approved for obesity treatment.) While states assess their capacities and the federal government considers its plans, Ro said her patients are getting a better shot at getting healthier by having access to the coverage
https://medlineplus.gov/ency/patientinstructions/000122.htm
A pilot study of chromium picolinate for weight loss
Contribution of NRF2 to sulfur metabolism and mitochondrial activity